Yayın:
NF-κB Inhibition Activity of Curcumin-Loaded Sterically Stabilized Micelles and Its Up-Regulator Effect on Enhancement of Cytotoxicity of a New Nano-Pirarubicin Formulation in the Treatment of Breast Cancer

dc.contributor.authorEskandari, Zahra
dc.contributor.authorBahadori, Fatemeh
dc.contributor.authorYapaoz, Melda Altkatoglu
dc.contributor.authorYenign, Vildan Betl
dc.contributor.authorKocyigit, Abdurrahim
dc.contributor.authorOnyuksel, Hayat
dc.date.accessioned2026-06-27T14:19:26Z
dc.date.issued2019
dc.description.abstractThis study aims to investigate the effects of co-administration of nano-Curcumin on anticancer effect of nano-Pirarubicin considering the fact that the clinical use of Pirarubicin and other anthracyclines has been limited by development of multidrug resistance (MDR) and based on previous data which have shown that Curcumin can down-regulate MDR proteins and suppress the activity of Nuclear factor-kappa B (NF-kappa B) a protein involved in chemoresistance. Nano micellar formulations of both Curcumin and Pirarubicin were separately synthesized using 1,2 -Distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-[poly (ethylene glycol); PEG MW 2,000] (DSPE-PEG2000). The produced sterically stabilized micelles (SSM) are very well known drug delivery systems in terms of their enhanced efficacy and good toxicity profile. We measured the differences of NF-kappa B levels in two different situations: when Pirarubicin is used alone and when it is co-administered with Curcumin. This study showed that co-administration of SSM-Curcumin (CSSM) and SSM-Pirarubicin (PSSM) with size of 12.81 nm enhances the efficacy of Pirarubicin by suppressing P65, an NF-kappa B subunit. Furthermore, we showed that SSM is able to successfully enhance water solubility and therapeutic stability of curcumin for using as a complementary agent.en
dc.description.sponsorshipBezmialem University Scientific Project Supporting Program [6.2018/10]
dc.description.sponsorshipResearch Fund of the Yildiz Technical University [FDK-2017-3111]
dc.description.urihttps://doi.org/10.25135/rnp.108.18.10.984
dc.identifier.doi10.25135/rnp.108.18.10.984
dc.identifier.endpage404
dc.identifier.issn1307-6167
dc.identifier.issue5
dc.identifier.startpage390
dc.identifier.urihttps://hdl.handle.net/20.500.14981/59260
dc.identifier.volume13
dc.identifier.wos000484075000004
dc.language.isoeng
dc.publisherACG PUBLICATIONS
dc.relation.ispartofRECORDS OF NATURAL PRODUCTS
dc.rightsopenAccess
dc.subjectCurcumin
dc.subjectpirarubicin
dc.subjectnanoparticles
dc.subjectNF-kappa B
dc.subjectbreast cancer
dc.subjectIN-VITRO
dc.subjectCELLS
dc.subjectAPOPTOSIS
dc.subjectBIOAVAILABILITY
dc.subjectPROLIFERATION
dc.subjectNMR
dc.subjectDIFERULOYLMETHANE
dc.subjectCHEMORESISTANCE
dc.subjectDEGRADATION
dc.subjectPlant Sciences
dc.subjectChemistry
dc.subjectPharmacology & Pharmacy
dc.titleNF-κB Inhibition Activity of Curcumin-Loaded Sterically Stabilized Micelles and Its Up-Regulator Effect on Enhancement of Cytotoxicity of a New Nano-Pirarubicin Formulation in the Treatment of Breast Cancer
dc.typeArticle
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar